539871 Share Price Performance
₹1,382.15
414.55 (42.84%)
9.1% undervalued intrinsic discount
₹1,520.00
Fair Value
Price ₹1,382.15
AnalystConsensusTarget ₹1,520.00
Fair Value₹1,520.00
Share Price₹1,382.15
9.1% undervalued intrinsic discount
Thyrocare Technologies Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
539871 Community Narratives
AN
Fair Value ₹1.52k 9.1% undervalued intrinsic discount
Upcoming Bonus Shares And Dividend Proposal Will Drive Shareholder Value
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
Upcoming Bonus Shares And Dividend Proposal Will Drive Shareholder Value
Key Takeaways Rapid network expansion and broader service offerings are increasing test volumes, driving sustained revenue and margin growth through operating leverage and higher-value tests. Focus on quality accreditation, technology, and digital partnerships strengthens market position, improves efficiency, and supports ongoing growth in demand and profitability.Read more
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
₹1.52k
9.1% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
16.83% p.a.
Profit Margin
22.58%
Future PE
40.43x
Share price in 2028
₹2.14k
Snowflake Analysis
Thyrocare Technologies Limited Key Details
About 539871
- Founded
- 1996
- Employees
- 1822
- CEO
- WebsiteView website
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
